AspenBio Pharma, Inc. 4
4 · AspenBio Pharma, Inc. · Filed Jul 18, 2006
Insider Transaction Report
Form 4
Donnelly Richard G
DirectorPresident & CEO
Transactions
- Award
Options (Right to Buy)
2006-07-14+100,000→ 100,000 totalExercise: $1.40From: 2007-01-01Exp: 2016-07-14→ Common Stock (100,000 underlying)
Holdings
- 221,537
Common Stock
- 28,571
Warrants (Right to Buy)
Exercise: $1.35From: 2005-05-06Exp: 2010-05-06→ Common Stock (28,571 underlying) - 500,000
Options (Right to Buy)
Exercise: $0.60From: 2005-02-01Exp: 2015-02-01→ Common Stock (500,000 underlying)
Footnotes (3)
- [F1]Options vest over three years, at the rate of 33.3% at the end of year one, 66.7% at the end of year two, and 100% at the end of year three.
- [F2]Units purchased at a unit price of $0.875, with each unit consisting of one warrant and one share of common stock.
- [F3]Options granted pursuant to Board approval on July 14, 2006. This transaction is exempt from 16(b) reporting requirements pursuant to Rule 16b-3(d).